937241

Tris Pharma Inc. — FEI 3004712471

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 12, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Monmouth Junction, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
683121 CFR 314.80(c)(2)Late submission of quarterly safety reports